Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.24.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Common Stock
Class A Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Dec. 29, 2022     106,151,000      
Beginning balance at Dec. 29, 2022 $ 1,657,176   $ 106 $ 482,312 $ 4,337 $ 1,170,421
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 6,741     6,741    
Exercise of stock options (in shares)     79,000      
Exercise of stock options 2,130     2,130    
Issuance of common stock upon vesting of restricted stock units (in shares)     117,000      
Shares issued under employee stock purchase plan (in shares)     43,000      
Shares issued under employee stock purchase plan 2,558     2,558    
Common stock redeemed for tax liability (in shares)     (119,000)      
Common stock redeemed for tax liability (10,863)     (10,863)    
Other comprehensive loss, net of tax (849)       (849)  
Net income 71,524         71,524
Ending balance (in shares) at Mar. 30, 2023     106,271,000      
Ending balance at Mar. 30, 2023 1,728,417   $ 106 482,878 3,488 1,241,945
Beginning balance (in shares) at Dec. 29, 2022     106,151,000      
Beginning balance at Dec. 29, 2022 1,657,176   $ 106 482,312 4,337 1,170,421
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive loss, net of tax (1,882)          
Net income 208,899          
Ending balance (in shares) at Sep. 28, 2023     106,570,000      
Ending balance at Sep. 28, 2023 1,885,476   $ 107 503,594 2,455 1,379,320
Beginning balance (in shares) at Mar. 30, 2023     106,271,000      
Beginning balance at Mar. 30, 2023 1,728,417   $ 106 482,878 3,488 1,241,945
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 8,306     8,306    
Exercise of stock options (in shares)     123,000      
Exercise of stock options 2,728     2,728    
Issuance of common stock upon vesting of restricted stock units (in shares)     8,000      
Common stock redeemed for tax liability (in shares)     (11,000)      
Common stock redeemed for tax liability (998)     (998)    
Other comprehensive loss, net of tax (126)       (126)  
Net income 71,452         71,452
Ending balance (in shares) at Jun. 29, 2023     106,391,000      
Ending balance at Jun. 29, 2023 1,809,779   $ 106 492,914 3,362 1,313,397
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 5,289     5,289    
Exercise of stock options (in shares)     134,000      
Exercise of stock options 3,051   $ 1 3,050    
Issuance of common stock upon vesting of restricted stock units (in shares)     7,000      
Shares issued under employee stock purchase plan (in shares)     41,000      
Shares issued under employee stock purchase plan 2,601     2,601    
Common stock redeemed for tax liability (in shares)     (3,000)      
Common stock redeemed for tax liability (260)     (260)    
Other comprehensive loss, net of tax (907)       (907)  
Net income 65,923         65,923
Ending balance (in shares) at Sep. 28, 2023     106,570,000      
Ending balance at Sep. 28, 2023 1,885,476   $ 107 503,594 2,455 1,379,320
Beginning balance (in shares) at Dec. 28, 2023   106,737,532 106,738,000      
Beginning balance at Dec. 28, 2023 1,930,990   $ 107 513,060 1,422 1,416,401
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 7,232     7,232    
Exercise of stock options (in shares)     171,000      
Exercise of stock options 3,854     3,854    
Issuance of common stock upon vesting of restricted stock units (in shares)     184,000      
Shares issued under employee stock purchase plan (in shares)     28,000      
Shares issued under employee stock purchase plan 2,720     2,720    
Common stock redeemed for tax liability (in shares)     (110,000)      
Common stock redeemed for tax liability (13,057)     (13,057)    
Other comprehensive loss, net of tax (970)       (970)  
Net income 50,032         50,032
Ending balance (in shares) at Mar. 28, 2024     107,011,000      
Ending balance at Mar. 28, 2024 1,980,801   $ 107 513,809 452 1,466,433
Beginning balance (in shares) at Dec. 28, 2023   106,737,532 106,738,000      
Beginning balance at Dec. 28, 2023 $ 1,930,990   $ 107 513,060 1,422 1,416,401
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 331,778          
Other comprehensive loss, net of tax $ (1,501)          
Net income 158,388          
Ending balance (in shares) at Sep. 26, 2024   107,223,985 107,224,000      
Ending balance at Sep. 26, 2024 2,111,055   $ 107 536,238 (79) 1,574,789
Beginning balance (in shares) at Mar. 28, 2024     107,011,000      
Beginning balance at Mar. 28, 2024 1,980,801   $ 107 513,809 452 1,466,433
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 8,355     8,355    
Exercise of stock options (in shares)     112,000      
Exercise of stock options 1,588     1,588    
Issuance of common stock upon vesting of restricted stock units (in shares)     13,000      
Common stock redeemed for tax liability (in shares)     (3,000)      
Common stock redeemed for tax liability (470)     (470)    
Other comprehensive loss, net of tax (346)       (346)  
Net income 56,666         56,666
Ending balance (in shares) at Jun. 27, 2024     107,133,000      
Ending balance at Jun. 27, 2024 2,046,594   $ 107 523,282 106 1,523,099
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation expense 10,031     10,031    
Exercise of stock options (in shares)     49,000      
Exercise of stock options 769     769    
Issuance of common stock upon vesting of restricted stock units (in shares)     18,000      
Shares issued under employee stock purchase plan (in shares)     31,000      
Shares issued under employee stock purchase plan 2,739     2,739    
Common stock redeemed for tax liability (in shares)     (7,000)      
Common stock redeemed for tax liability (583)     (583)    
Other comprehensive loss, net of tax (185)       (185)  
Net income 51,690         51,690
Ending balance (in shares) at Sep. 26, 2024   107,223,985 107,224,000      
Ending balance at Sep. 26, 2024 $ 2,111,055   $ 107 $ 536,238 $ (79) $ 1,574,789